NFE2L2 and cancer: Future studies will be required to unravel the relative contributions of necrotic versus non-necrotic stressors in vivo and to define the downstream signaling pathways and mechanisms by which NRF2-imprinted stress-TAMs rewire cancer cell growth, EMT state, and T-cell functions.